What’s new for Good Pharmacovigilance Practices (GVP) in China
In collaboration with Pharma to Market, join us for a series of two complimentary webinars as we give you an introduction into the latest policy updates on the Good Pharmacovigilance Practices (GVP) in China, Singapore & Malaysia in the final week of May 2022.
What’s new in China for Pharmacovigilance?
The China webinar will cover:
- China PV framework
- What’s new in China’s GVP policies?
- What are the GVP requirements in China?
- Best practices for compliance with China’s GVP requirements
- Q&A
Date and Time: 25th May (wed) 5:00-6:00 pm China time
Pharmacovigilance in Malaysia and Singapore
The Malaysia/Singapore webinar will cover:
- Overview of Pharmacovigilance framework in Singapore and Malaysia
- PV-related requirements during pre-market phase
- Post- Market PV obligations of licence holders
- AE/ADR reporting requirements
- Periodic Benefit-Risk Evaluation Reports (PBRER) and Risk Management
- Plan (RMP) requirements
Date and Time: 24th May (Tue) 5:00 – 6:00 Singapore time
Pharmacovigilance in Malaysia and Singapore
Date:
24 May 2022, Tuesday
Time:
17:00 – 18:00 Singapore/Malaysia
19:00 – 20:00 Sydney
05:00 – 06:00 EST
11:00 – 12:00 CET
What’s new in China for Pharmacovigilance?
Date:
25 May 2022, Wednesday
Time:
17:00 – 18:00 China
19:00 – 20:00 Sydney
05:00 – 06:00 EST
11:00 – 12:00 CET
